MX347195B - Sistema de administración transdérmica de fármacos y método para usar el mismo. - Google Patents
Sistema de administración transdérmica de fármacos y método para usar el mismo.Info
- Publication number
- MX347195B MX347195B MX2013008543A MX2013008543A MX347195B MX 347195 B MX347195 B MX 347195B MX 2013008543 A MX2013008543 A MX 2013008543A MX 2013008543 A MX2013008543 A MX 2013008543A MX 347195 B MX347195 B MX 347195B
- Authority
- MX
- Mexico
- Prior art keywords
- delivery system
- drug delivery
- transdermal drug
- steroid
- adhesive layer
- Prior art date
Links
- 238000013271 transdermal drug delivery Methods 0.000 title abstract 4
- 238000000034 method Methods 0.000 title 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 abstract 3
- 239000010410 layer Substances 0.000 abstract 3
- 150000003431 steroids Chemical class 0.000 abstract 3
- 210000000744 eyelid Anatomy 0.000 abstract 2
- 241001608562 Chalazion Species 0.000 abstract 1
- 206010065062 Meibomian gland dysfunction Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 229960003099 amcinonide Drugs 0.000 abstract 1
- ILKJAFIWWBXGDU-MOGDOJJUSA-N amcinonide Chemical compound O([C@@]1([C@H](O2)C[C@@H]3[C@@]1(C[C@H](O)[C@]1(F)[C@@]4(C)C=CC(=O)C=C4CC[C@H]13)C)C(=O)COC(=O)C)C12CCCC1 ILKJAFIWWBXGDU-MOGDOJJUSA-N 0.000 abstract 1
- 229960001102 betamethasone dipropionate Drugs 0.000 abstract 1
- CIWBQSYVNNPZIQ-XYWKZLDCSA-N betamethasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CIWBQSYVNNPZIQ-XYWKZLDCSA-N 0.000 abstract 1
- 208000010217 blepharitis Diseases 0.000 abstract 1
- 229960004703 clobetasol propionate Drugs 0.000 abstract 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- DMKSVUSAATWOCU-HROMYWEYSA-N loteprednol etabonate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)OCCl)(OC(=O)OCC)[C@@]1(C)C[C@@H]2O DMKSVUSAATWOCU-HROMYWEYSA-N 0.000 abstract 1
- 229960003744 loteprednol etabonate Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/164,037 US8900626B2 (en) | 2011-06-20 | 2011-06-20 | Transdermal drug delivery system and method of using the same |
| PCT/US2012/043126 WO2012177626A1 (en) | 2011-06-20 | 2012-06-19 | Transdermal drug delivery system and method of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013008543A MX2013008543A (es) | 2013-08-12 |
| MX347195B true MX347195B (es) | 2017-04-19 |
Family
ID=47353860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013008543A MX347195B (es) | 2011-06-20 | 2012-06-19 | Sistema de administración transdérmica de fármacos y método para usar el mismo. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8900626B2 (enExample) |
| EP (1) | EP2720748B1 (enExample) |
| JP (2) | JP6296977B2 (enExample) |
| KR (2) | KR20190026963A (enExample) |
| CN (1) | CN103429295B (enExample) |
| CA (1) | CA2831095C (enExample) |
| ES (1) | ES2627514T3 (enExample) |
| MX (1) | MX347195B (enExample) |
| WO (1) | WO2012177626A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1591110B1 (en) * | 2003-01-22 | 2015-03-18 | Senju Pharmaceutical Co., Ltd. | Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye |
| US8915253B2 (en) | 2005-07-18 | 2014-12-23 | Tearscience, Inc. | Method and apparatus for treating gland dysfunction employing heated medium |
| US20080114423A1 (en) | 2006-05-15 | 2008-05-15 | Grenon Stephen M | Apparatus for inner eyelid treatment of meibomian gland dysfunction |
| WO2013003594A2 (en) | 2011-06-28 | 2013-01-03 | Tearscience, Inc. | Methods and systems for treating meibomian gland dysfunction using radio-frequency energy |
| US20070060988A1 (en) | 2005-07-18 | 2007-03-15 | Grenon Stephen M | Melting meibomian gland obstructions |
| US7981145B2 (en) | 2005-07-18 | 2011-07-19 | Tearscience Inc. | Treatment of meibomian glands |
| US20090043365A1 (en) | 2005-07-18 | 2009-02-12 | Kolis Scientific, Inc. | Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma |
| US8950405B2 (en) * | 2006-05-15 | 2015-02-10 | Tearscience, Inc. | Treatment of obstructive disorders of the eye or eyelid |
| US9314369B2 (en) | 2006-05-15 | 2016-04-19 | Tearscience, Inc. | System for inner eyelid treatment of meibomian gland dysfunction |
| US10842670B2 (en) | 2012-08-22 | 2020-11-24 | Johnson & Johnson Vision Care, Inc. | Apparatuses and methods for diagnosing and/or treating lipid transport deficiency in ocular tear films, and related components and devices |
| US9211397B2 (en) * | 2012-12-19 | 2015-12-15 | Senju Usa, Inc. | Patch for treatment of eyelid disease containing clobetasol |
| US9820954B2 (en) | 2015-08-19 | 2017-11-21 | Jenivision Inc. | Quantitative peri-orbital application of ophthalmology drugs |
| US12011388B2 (en) | 2016-03-01 | 2024-06-18 | The Hilsinger Company Parent, Llc | Therapeutic thermal compress with phase-change material |
| US12029681B2 (en) | 2016-03-01 | 2024-07-09 | The Hilsinger Company Parent, Llc | Therapeutic eye mask system |
| US12156831B2 (en) | 2016-03-01 | 2024-12-03 | The Hilsinger Company Parent, Llc | Therapeutic eye compress system |
| US20190167568A1 (en) * | 2016-06-29 | 2019-06-06 | Senju Usa, Inc. | Transdermal Drug Delivery System and Method for Using Same |
| USD871598S1 (en) | 2016-11-30 | 2019-12-31 | Bruder Healthcare Company, Llc | Therapeutic eye mask |
| USD844795S1 (en) | 2016-11-30 | 2019-04-02 | Bruder Healthcare Company, Llc | Therapeutic eye mask |
| BR112020008046A2 (pt) | 2017-11-21 | 2020-10-27 | Axerovision, Inc. | composições e métodos de uso para tratamento de inflamação anormal em glândulas secretoras perioculares ou na superfície ocular |
| US11759472B2 (en) | 2017-11-21 | 2023-09-19 | Cs Pharmaceuticals Limited | Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface |
| JP7332602B2 (ja) * | 2017-12-28 | 2023-08-23 | センジュ ユーエスエー、インコーポレイテッド | 経皮薬物送達システムおよびその使用方法 |
| CA3092966A1 (en) | 2018-03-02 | 2019-09-06 | The Schepens Eye Research Institute | System and method for treating meibomian gland dysfunction |
| WO2022010864A1 (en) * | 2020-07-06 | 2022-01-13 | Kindeva Drug Delivery L.P. | Drug delivery device for delivery of clobetasol propionate |
| EP4247367A4 (en) | 2020-11-23 | 2024-10-16 | Sight Sciences, Inc. | Formulations and methods for treating conditions of the eye |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1047519A (en) | 1963-06-11 | 1966-11-02 | Glaxo Lab Ltd | 17ª‡,21-diesters of 11,17,21-trihydroxy steroid compounds |
| GB1253831A (en) | 1968-01-19 | 1971-11-17 | Glaxo Lab Ltd | 9alpha,21-DIHALOPREGNANE COMPOUNDS |
| ZA744259B (en) | 1973-08-17 | 1975-06-25 | American Cyanamid Co | Topical steroid |
| US4666441A (en) | 1985-12-17 | 1987-05-19 | Ciba-Geigy Corporation | Multicompartmentalized transdermal patches |
| US4954343A (en) * | 1986-03-29 | 1990-09-04 | Nitto Electric Industrial Co., Ltd. | Dermal pharmaceutical preparations |
| WO1989003390A1 (en) | 1987-10-13 | 1989-04-20 | Bodor Nicholas S | Soft steroids having anti-inflammatory activity |
| ZA966579B (en) * | 1995-08-04 | 1998-02-02 | Wakamoto Pharma Co Ltd | O/W emulsion composition for eye drops. |
| JP2001009985A (ja) * | 1999-07-02 | 2001-01-16 | Hisamitsu Pharmaceut Co Inc | 貼付剤用包装袋及び包装貼付剤 |
| WO2001026648A1 (en) | 1999-10-13 | 2001-04-19 | Senju Pharmaceutical Co., Ltd. | Ophthalmic adhesive preparations for percutaneous absorption |
| US20050058695A1 (en) * | 2002-05-30 | 2005-03-17 | Watson Pharmaccuticals, Inc. | Norethindrone sustained release formulations and methods associated therewith |
| EP1591110B1 (en) * | 2003-01-22 | 2015-03-18 | Senju Pharmaceutical Co., Ltd. | Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye |
| US20050245497A1 (en) * | 2004-04-08 | 2005-11-03 | Penfold Philip L | Treatment of ophthalmic conditions |
| US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
| US20070053964A1 (en) | 2004-05-21 | 2007-03-08 | Akiharu Isowaki | Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist |
| KR20070104912A (ko) | 2005-02-17 | 2007-10-29 | 센주 세이야꾸 가부시키가이샤 | 안과용 고형 외용약제 |
| JP2008538754A (ja) * | 2005-04-11 | 2008-11-06 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ | 薬剤を含んだ所定のレイヤパターンを有する複層構造体 |
| JP5315051B2 (ja) | 2005-07-08 | 2013-10-16 | 千寿製薬株式会社 | オロパタジンを含む眼科用経皮吸収型製剤 |
| US20090143359A1 (en) | 2005-07-08 | 2009-06-04 | Akiharu Isowaki | Percutaneously Absorptive Ophthalmic Preparation Comprising Epinastine |
| JPWO2007013661A1 (ja) | 2005-07-26 | 2009-02-12 | 千寿製薬株式会社 | 眼科用経皮吸収型製剤 |
| KR20090042956A (ko) | 2006-08-28 | 2009-05-04 | 센주 세이야꾸 가부시키가이샤 | 안과 경피 흡수형 제제 |
| JP5485135B2 (ja) | 2008-02-27 | 2014-05-07 | 久光製薬株式会社 | 貼付製剤 |
| US20090297590A1 (en) | 2008-05-30 | 2009-12-03 | Masahiro Yamaji | Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease |
| AU2009261285B2 (en) * | 2008-06-19 | 2012-12-13 | Fuso Pharmaceutical Industries, Ltd | Peptide derivative and composition for promoting tear secretion comprising the same |
| US10201548B2 (en) | 2009-03-06 | 2019-02-12 | Sun Pharma Global Fze | Methods for treating ocular inflammatory diseases |
| TW201039815A (en) * | 2009-04-13 | 2010-11-16 | Resolvyx Pharmaceuticals Inc | Compositions and methods for the treatment of inflammation |
| TWI445708B (zh) * | 2009-09-02 | 2014-07-21 | Irm Llc | 作為ｔｌｒ活性調節劑之化合物及組合物 |
| ES2752008T3 (es) | 2009-10-30 | 2020-04-02 | Intratus Inc | Métodos y composiciones para la liberación sostenida de fármacos |
| JP2013527559A (ja) * | 2010-03-31 | 2013-06-27 | キーケルト アーゲー | 自動車用のアクチュエータおよび施錠装置および方法 |
| EP2505618A1 (en) * | 2011-04-01 | 2012-10-03 | Fábrica Nacional De Moneda Y Timbre | Use of electromagnetic wave absorbing markers for the aunthentication of security documents |
-
2011
- 2011-06-20 US US13/164,037 patent/US8900626B2/en not_active Expired - Fee Related
-
2012
- 2012-06-19 CN CN201280006627.7A patent/CN103429295B/zh not_active Expired - Fee Related
- 2012-06-19 JP JP2014517085A patent/JP6296977B2/ja not_active Expired - Fee Related
- 2012-06-19 ES ES12802854.5T patent/ES2627514T3/es active Active
- 2012-06-19 CA CA2831095A patent/CA2831095C/en not_active Expired - Fee Related
- 2012-06-19 MX MX2013008543A patent/MX347195B/es active IP Right Grant
- 2012-06-19 WO PCT/US2012/043126 patent/WO2012177626A1/en not_active Ceased
- 2012-06-19 EP EP12802854.5A patent/EP2720748B1/en not_active Not-in-force
- 2012-06-19 KR KR1020197006444A patent/KR20190026963A/ko not_active Ceased
- 2012-06-19 KR KR1020137025876A patent/KR102107977B1/ko not_active Expired - Fee Related
-
2016
- 2016-10-14 JP JP2016202990A patent/JP2017048201A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP6296977B2 (ja) | 2018-03-20 |
| WO2012177626A1 (en) | 2012-12-27 |
| US8900626B2 (en) | 2014-12-02 |
| JP2014519955A (ja) | 2014-08-21 |
| CN103429295B (zh) | 2017-03-29 |
| CA2831095C (en) | 2015-12-01 |
| CN103429295A (zh) | 2013-12-04 |
| US20120321673A1 (en) | 2012-12-20 |
| KR20140019790A (ko) | 2014-02-17 |
| ES2627514T3 (es) | 2017-07-28 |
| EP2720748B1 (en) | 2017-05-17 |
| KR20190026963A (ko) | 2019-03-13 |
| CA2831095A1 (en) | 2012-12-27 |
| MX2013008543A (es) | 2013-08-12 |
| EP2720748A1 (en) | 2014-04-23 |
| EP2720748A4 (en) | 2014-11-26 |
| JP2017048201A (ja) | 2017-03-09 |
| KR102107977B1 (ko) | 2020-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX347195B (es) | Sistema de administración transdérmica de fármacos y método para usar el mismo. | |
| JP2014519955A5 (enExample) | ||
| IN2012DN01225A (enExample) | ||
| MX381164B (es) | Composiciones tópicas de corticosteroides. | |
| MY161021A (en) | Controlled release corticosteroid and methods for the treatment of otic disorders | |
| SG194155A1 (en) | Multilayer thin film drug delivery device and methods of making and using the same | |
| BRPI0713257B8 (pt) | sistema terapêutico transdérmico para a aplicação de norelgestromina | |
| PH12014501351A1 (en) | Fluorinated estrogen receptor modulators and uses thereof | |
| ATE496617T1 (de) | Abgabesystem mit gesteuerter freisetzung zur nasalen anwendung von neurotransmittern | |
| UA109785C2 (uk) | Композиція фармацевтичного аерозолю, яка включає аналог вітаміну d і кортикостероїд | |
| SG10201907588XA (en) | Androgen Receptor Modulators And Uses Thereof | |
| MY183873A (en) | Transdermal therapeutic system for application of an agent | |
| CA3010829A1 (en) | Gel compositions for transdermal delivery to maximize drug concentrations in the stratum corneum and serum and methods of use thereof | |
| BR112014018439A8 (pt) | Terapias de reposição de hormônio transdérmica | |
| IN2014DN09817A (enExample) | ||
| MY182222A (en) | Pharmaceutical compositions and methods of use of 4-pregenen- 11?-17-21-triol-3,20-dione derivatives | |
| MX2016008138A (es) | Sistema para el suministro transdermico de ingredientes activos. | |
| EP3513789A3 (en) | Prophylactic and therapeutic agents for fgfr3 diseases | |
| AU2013330679A8 (en) | Combination drug comprising gemigliptin and metformin, and method for the preparation thereof | |
| BR112012029697A2 (pt) | polissacarídeo da semente de tamarindo para uso no tratamento de doenças inflamatórias | |
| WO2009076413A3 (en) | Methods, devices and compositions for controlled drug delivery to injured myocardium | |
| PH12014501573A1 (en) | Topical pharmaceutical compositions comprising bexarotene and a corticosteroids | |
| BR112022012111A2 (pt) | Sistema terapêutico transdérmico contendo agomelatina | |
| WO2014123543A3 (en) | Skin permeating and cell entering (space) peptides and methods of use therefor | |
| WO2012111996A3 (ko) | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |